Biomerica Inc financial data

Symbol
BMRA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
17571 Von Karman Avenue, Irvine, California
State of incorporation
Delaware
Fiscal year end
May 31
Latest financial report
Q1 2024 - Apr 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 579 % +21%
Quick Ratio 105 % -13.8%
Debt-to-equity 25.6 % -28.3%
Return On Equity -64 % +32.7%
Return On Assets -51 % +27.3%
Operating Margin -123 % -64.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.8M shares 0%
Common Stock, Shares, Outstanding 16.8M shares +24.7%
Entity Public Float 42.7M USD -23.3%
Common Stock, Value, Issued 1.35M USD +24.7%
Weighted Average Number of Shares Outstanding, Basic 16.8M shares +24.8%
Weighted Average Number of Shares Outstanding, Diluted 16.8M shares +24.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.41M USD -43.3%
Revenue from Contract with Customer, Excluding Assessed Tax 5.41M USD -43.3%
Cost of Revenue 4.79M USD -43.6%
Research and Development Expense 1.6M USD -6.69%
Operating Income (Loss) -6.68M USD +6.54%
Nonoperating Income (Expense) 375K USD +139%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.3M USD +10.7%
Income Tax Expense (Benefit) 48K USD +0.28%
Net Income (Loss) Attributable to Parent -6.35M USD +10.7%
Earnings Per Share, Basic -0.37 USD/shares +31.5%
Earnings Per Share, Diluted -0.37 USD/shares +31.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.32M USD +59%
Accounts Receivable, after Allowance for Credit Loss, Current 1.13M USD +49.8%
Inventory, Net 2.13M USD +3.14%
Assets, Current 8.85M USD +36.5%
Property, Plant and Equipment, Net 194K USD -14.8%
Operating Lease, Right-of-Use Asset 817K USD -25.8%
Intangible Assets, Net (Excluding Goodwill) 216K USD +39.7%
Other Assets, Noncurrent 104K USD +32.3%
Assets 10.3M USD +26%
Accounts Payable, Current 344K USD -53.3%
Employee-related Liabilities, Current 702K USD +34.9%
Accrued Liabilities, Current 548K USD +132%
Liabilities, Current 1.99M USD +42.7%
Operating Lease, Liability, Noncurrent 543K USD -34.5%
Liabilities 2.53M USD +13.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -102K USD +8.03%
Retained Earnings (Accumulated Deficit) -46.8M USD -15.7%
Stockholders' Equity Attributable to Parent 7.81M USD +30.4%
Liabilities and Equity 10.3M USD +26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.67M USD -6.42%
Net Cash Provided by (Used in) Financing Activities 9.39M USD +292%
Net Cash Provided by (Used in) Investing Activities -63K USD -85.3%
Common Stock, Shares Authorized 25M shares 0%
Common Stock, Shares, Issued 16.8M shares +24.7%
Common Stock, Par or Stated Value Per Share 0.08 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.73M USD -1196%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.35M USD -67.1%
Deferred Tax Assets, Valuation Allowance 8.94M USD +28.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 8.94M USD +28.3%
Operating Lease, Liability 862K USD -26.8%
Payments to Acquire Property, Plant, and Equipment 21K USD -38.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.34M USD +11.4%
Lessee, Operating Lease, Liability, to be Paid 933K USD -28.9%
Operating Lease, Liability, Current 319K USD -8.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 195K USD -49%
Lessee, Operating Lease, Liability, to be Paid, Year One 373K USD +0.81%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 71K USD -47.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6K USD -98.5%
Deferred Tax Assets, Operating Loss Carryforwards 5.82M USD +33.8%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -51K USD -113%
Preferred Stock, Shares Authorized 4.43M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 101K USD -73.7%
Operating Lease, Payments 87K USD +1.16%
Additional Paid in Capital 53.3M USD +17.4%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -1K USD 0%
Amortization of Intangible Assets 16K USD -93.1%
Depreciation, Depletion and Amortization 76K USD -77.6%
Deferred Tax Assets, Net of Valuation Allowance 8.09M USD
Share-based Payment Arrangement, Expense 1.05M USD -15.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares